Media briefing on COVID-19 - 11/01/2021
Date:
11/01/2021
00:00:12
FC Hello, all. I am Fadela Chaib, speaking to you from WHO headquarters in Geneva and I welcome you to our global COVID-19 press conference today, Monday January 11th. Present in the room are Who Director-General, Dr Tedros, Dr Mike Ryan, Executive Director, health Emergencies, Dr Maria Van Kerkhove, Dr Mariangela Simao, Assistant Director-General, Access to Medicines and Health ...
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Americas/epidemiology, Epidemiological Monitoring, Viral Vaccines/supply & distribution, Access to Essential Medicines and Health Technologies, Health Equity, Immunization Programs/organization & administration, Risk Groups, Health Personnel, Essential Public Health Functions, Social Isolation, Masks, Quarantine, COVID-19, Ghebreyesus, Tedros Adhanom , Covax
Media briefing on COVID-19 - 25/01/2021
Date:
25/01/2021
00:00:19
FC Hello, all. I am Fadela Chaib, speaking to you from WHO headquarters in Geneva and welcoming you to our global COVID-19 press conference today, Monday 25th January. We will welcome two guests who will tell us more about compelling research on the economic benefit of funding efforts to ensure equitable access to COVID-19 vaccines.
Simultaneous interoperation is provided in the...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Americas/epidemiology, Epidemiological Monitoring, Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/supply & distribution, Universal Health Coverage, Risk Groups, Health Personnel, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Mutation/genetics, DNA, Viral/genetics, Social Isolation, Quarantine, Access to Essential Medicines and Health Technologies, Health Equity, COVID-19, Ghebreyesus, Tedros Adhanom , Covax
Media briefing on COVID-19 - 29/01/2021
Date:
29/01/2021
00:02:52
FC Hello, all. I am Fadela Chaib, speaking to you from WHO headquarters in Geneva and welcoming you to our global COVID-19 press conference today, Friday 29th January. We will be joined by guests whom I will let Dr Tedros introduce in a moment. We have simultaneous interpretation in the six official UN languages plus Portuguese and Hindi.
Let me tell you who is in the room here....
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Americas/epidemiology, Epidemiological Monitoring, Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/supply & distribution, Risk Groups, Health Personnel, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Mutation/genetics, DNA, Viral/genetics, Social Isolation, Quarantine, Access to Essential Medicines and Health Technologies, Health Equity, COVID-19, Ghebreyesus, Tedros Adhanom , Covax
Media briefing on COVID-19 - 05/02/2021
Date:
05/02/2021
00:00:21
FC Hello, all. I am Fadela Chaib, speaking to you from the WHO headquarters in Geneva and welcoming you all to our global COVID-19 press conference today, Friday 5th February. We have simultaneous interpretation in the six UN languages plus Portuguese and Hindi. I would like to introduce to you the WHO participants.
Present in the room are the WHO Director-General, Dr Tedros, Dr...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Americas/epidemiology, Epidemiological Monitoring, Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/supply & distribution, Financial Resources in Health/economics, Risk Groups, Health Personnel, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Mutation/genetics, DNA, Viral/genetics, Social Isolation, Access to Essential Medicines and Health Technologies, COVID-19, Ghebreyesus, Tedros Adhanom , Covax
Media briefing on COVID-19 - 15/02/2021
Date:
15/02/2021
00:00:31
FC Hello, everyone. This is Fadela Chaib speaking to you from WHO headquarters in Geneva and welcoming you to our global COVID-19 press conference today, Monday 15th February. We have simultaneous interpretation in the six official UN languages plus Portuguese and Hindi. Let me introduce to you the participants.
Present in the room are WHO Director-General, Dr Tedros, Dr Mike R...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Americas/epidemiology, Epidemiological Monitoring, Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/supply & distribution, Health Consortia, Risk Groups, Health Personnel, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Mutation/genetics, DNA, Viral/genetics, Social Isolation, Quarantine, Access to Essential Medicines and Health Technologies, Health Equity, Financial Resources in Health/economics, Communication, COVID-19, Ghebreyesus, Tedros Adhanom , Covax, Infodemic
Media briefing on COVID-19 - 12/03/2021
Date:
12/03/2021
00:00:00
CL 12th March 2021. My name is Christian Lindmeier and I'm welcoming you to today's global COVID-19 press conference. We have as usual simultaneous interpretation available in the six official UN languages, Arabic, Chinese, French, English, Spanish and Russian, plus Portuguese and Hindi. Let me now introduce to you the participants.
Present in the room are Dr Tedros Adhanom Ghebreyesus, W...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Americas/epidemiology, Epidemiological Monitoring, Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/supply & distribution, Risk Groups, Health Personnel, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Mutation/genetics, DNA, Viral/genetics, Social Isolation, Quarantine, Viral Vaccines/adverse effects, Financial Resources in Health/economics, Oxygen/supply & distribution, Access to Essential Medicines and Health Technologies, COVID-19, Ghebreyesus, Tedros Adhanom , Covax
Media briefing on COVID-19 - 05/03/2021
Date:
05/03/2021
00:00:30
CL Hello and today wherever you are listening today, this Friday 5th May [sic] 2021. My name is Christian Lindmeier and I'm welcoming you to today's global COVID-19 press conference. As usual we'll have simultaneous interpretation provided in the six official UN languages, Arabic, Chinese, French, English, Spanish and Russian, as well as Portuguese and Hindi.
We'll have a special guest w...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Americas/epidemiology, Epidemiological Monitoring, Health Consortia, Access to Essential Medicines and Health Technologies, Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/supply & distribution, Financial Resources in Health/economics, Risk Groups, Health Personnel, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Mutation/genetics, DNA, Viral/genetics, Social Isolation/psychology, Quarantine/psychology, Health Equity, Mental Health, COVID-19, Ghebreyesus, Tedros Adhanom , Covax
Media briefing on COVID-19 - 01/03/2021
Date:
01/03/2021
00:00:43
CL Hello, good morning, good afternoon, good day and welcome to today's global COVID-19 press conference out of WHO headquarters in Geneva. My name is Christian Lindmeier and I am welcoming you to today's briefing. We have simultaneous interpretation as always in the six official UN languages, Arabic, Chinese, French, English, Spanish and Russian, plus Portuguese and Hindi availa...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Americas/epidemiology, Epidemiological Monitoring, Access to Essential Medicines and Health Technologies, Health Consortia, Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/supply & distribution, Financial Resources in Health/economics, Risk Groups, Health Personnel, Coronavirus Infections/genetics, Pneumonia, Viral/genetics, Mutation/genetics, DNA, Viral/genetics, Social Isolation, Quarantine, COVID-19, Ghebreyesus, Tedros Adhanom , Covax
Webinario: protección de poblaciones en situación de vulnerabilidad en el contexto de COVID-19
Date:
15/12/2020
Protección de poblaciones en situación de vulnerabilidad en el contexto de COVID-19: Lanzamiento de la Guía para la implementación de intervenciones de salud pública no farmacéuticas en poblaciones en situación de vulnerabilidad en el contexto de COVID-19
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Quarantine/organization & administration, Social Isolation, Masks, Vulnerable Populations, Health of Indigenous Peoples, Poverty Areas, 50207, Social Protection in Health, Americas/epidemiology, Access to Essential Medicines and Health Technologies, Equity in Access to Health Services, Socioeconomic Factors, Hand Disinfection, 50334, Public Health Systems, Epidemiological Monitoring, Risk Groups, COVID-19, Silva Jr, Jarbas Barbosa da
Webinar: protecting populations in vulnerable situations in the context of COVID-19
Date:
15/12/2020
Protección de poblaciones en situación de vulnerabilidad en el contexto de COVID-19: Lanzamiento de la Guía para la implementación de intervenciones de salud pública no farmacéuticas en poblaciones en situación de vulnerabilidad en el contexto de COVID-19
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Quarantine/organization & administration, Social Isolation, Masks, Vulnerable Populations, Health of Indigenous Peoples, Poverty Areas, 50207, Social Protection in Health, Americas/epidemiology, Access to Essential Medicines and Health Technologies, Equity in Access to Health Services, Socioeconomic Factors, Hand Disinfection, 50334, Public Health Systems, Epidemiological Monitoring, Risk Groups, COVID-19, Silva Jr, Jarbas Barbosa da